Literature DB >> 5114966

Botulinal toxins and the problem of nomenclature of simple toxins.

C Lamanna, G Sakaguchi.   

Abstract

Mesh:

Substances:

Year:  1971        PMID: 5114966      PMCID: PMC378388          DOI: 10.1128/br.35.3.242-249.1971

Source DB:  PubMed          Journal:  Bacteriol Rev        ISSN: 0005-3678


× No keyword cloud information.
  31 in total

1.  [Existence of tetanus toxin under several aggregation conditions].

Authors:  M RAYNAUD; A TURPIN; B BIZZINI
Journal:  Ann Inst Pasteur (Paris)       Date:  1960-08

2.  Activation of Clostridium botulinum type E toxin by trypsin.

Authors:  J T DUFF; G G WRIGHT; A YARINSKY
Journal:  J Bacteriol       Date:  1956-10       Impact factor: 3.490

3.  Purification of tetanus toxin.

Authors:  J F LARGIER
Journal:  Biochim Biophys Acta       Date:  1956-09

4.  Extraction, purification, and properties of Bacillus sotto toxin.

Authors:  T A ANGUS
Journal:  Can J Microbiol       Date:  1956-06       Impact factor: 2.419

5.  Pneumococcal Hemolysin: The Preparation of Concentrates, and Their Action on Red Cells.

Authors:  B Cohen; S P Halbert; M E Perkins
Journal:  J Bacteriol       Date:  1942-05       Impact factor: 3.490

6.  ACTIVITY OF TYPE A BOTULINAL TOXIN AND HEMAGGLUTININ EXPOSED TO PROTEOLYTIC ENZYME.

Authors:  E A Meyer; C Lamanna
Journal:  J Bacteriol       Date:  1959-08       Impact factor: 3.490

7.  The lack of identity between hemagglutinin and the toxin of type A botulinal organism.

Authors:  C LAMANNA; J P LOWENTHAL
Journal:  J Bacteriol       Date:  1951-06       Impact factor: 3.490

8.  Diphtheria toxin subunit active in vitro.

Authors:  R J Collier; H A Cole
Journal:  Science       Date:  1969-06-06       Impact factor: 47.728

9.  Rapid bioassay for Clostridium botulinum type-E toxins by intravenous injection into mice.

Authors:  G Sakaguchi; S Sakaguchi; H Kondo
Journal:  Jpn J Med Sci Biol       Date:  1968-12

10.  Chromatographic fractionation of the crystalline toxin of Clostridium botulinum type A.

Authors:  B R Dasgupta; D A Boroff; E Rothstein
Journal:  Biochem Biophys Res Commun       Date:  1966-03-22       Impact factor: 3.575

View more
  12 in total

1.  Role of a protease in natural activation of Clostridium botulinum neurotoxin.

Authors:  B R Das Gupta; H Sugiyama
Journal:  Infect Immun       Date:  1972-10       Impact factor: 3.441

2.  Activation of a toxic component of Clostridium botulinum types C and D by trypsin.

Authors:  M W Eklund; F T Poysky
Journal:  Appl Microbiol       Date:  1972-07

3.  Comparison of the presynaptic actions of botulinum toxin and beta-bungarotoxin on neuromuscular transmission.

Authors:  C C Chang; M C Huang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

4.  Development of antitoxin with each of two complementary fragments of Clostridium botulinum type B derivative toxin.

Authors:  S Kozaki; S Miyazaki; G Sakaguchi
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

Review 5.  Clostridium botulinum neurotoxin.

Authors:  H Sugiyama
Journal:  Microbiol Rev       Date:  1980-09

6.  Purification and some properties of progenitor toxins of Clostridium botulinum type B.

Authors:  S Kozaki; S Sakaguchi; G Sakaguchi
Journal:  Infect Immun       Date:  1974-10       Impact factor: 3.441

7.  Interaction of botulinum type A, B and E derivative toxins with synaptosomes of rat brain.

Authors:  S Kozaki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-07       Impact factor: 3.000

8.  Characterization of a halo-acid-tolerant variant of Clostridium botulinum B-aphis.

Authors:  T J Montville
Journal:  Appl Environ Microbiol       Date:  1984-08       Impact factor: 4.792

9.  Oral toxicities of Clostridium botulinum toxins in response to molecular size.

Authors:  I Ohishi; S Sugii; G Sakaguchi
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

10.  Molecular construction of Clostridium botulinum type A toxins.

Authors:  S Sugii; G Sakaguchi
Journal:  Infect Immun       Date:  1975-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.